aluates Reports

$ 0.0

Automative

Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-7Y13520

Global Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Market Research Report 2023

BUY CHAPTERS

Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-7Y13520

Report

September 2024

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Sanofi

KM Biologics

Serum Institute of India

Walvax Biotechnology

Sinopharm

Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market Size

The global market for Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine was estimated to be worth US$ 5315 million in 2023 and is forecast to a readjusted size of US$ 6874.5 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030

Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market

DTaP (diphtheria, tetanus, and acellular pertussis) vaccine, which is given to children. DT (diphtheria and tetanus) vaccine, which is given to children. Tdap (combined tetanus, diphtheria and acellular pertussis) vaccine, which is given to adolescents and adults.

Increasing awareness about the importance of vaccination, growing incidence of diphtheria, tetanus, and pertussis infections, and government immunization programs are key drivers of market expansion. Advancements in vaccine technology, such as the development of acellular pertussis vaccines, have improved safety and efficacy, further boosting market growth. Additionally, the introduction of combination vaccines that provide protection against multiple diseases has simplified immunization schedules and increased convenience for healthcare providers and patients. However, challenges such as vaccine hesitancy, high manufacturing costs, and limited accessibility in certain regions may hinder market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine by region & country, by Type, and by Application.

The Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine.

Market Segmentation

Scope of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market Report

Report Metric	Details
Report Name	Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market
Forecasted market size in 2030	US$ 6874.5 million
CAGR	3.7%
Forecasted years	2024 - 2030
Segment by Type:	DTaP Tdap
Segment by Application	Child Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, GSK, KM Biologics, Serum Institute of India, Walvax Biotechnology, Sinopharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market size in 2030?

Ans: The Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market size in 2030 will be US$ 6874.5 million.

Who are the main players in the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market report?

Ans: The main players in the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market are Sanofi, GSK, KM Biologics, Serum Institute of India, Walvax Biotechnology, Sinopharm

What are the Application segmentation covered in the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market report?

Ans: The Applications covered in the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market report are Child, Adult

What are the Type segmentation covered in the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market report?

Ans: The Types covered in the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine - Market report are DTaP, Tdap

Recommended Reports

Combination Vaccines

Pertussis & DPT Vaccines

Pediatric & Child Vaccines

1 Market Overview

1.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Introduction

1.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Forecast

1.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value (2019-2030)

1.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume (2019-2030)

1.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Price (2019-2030)

1.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Trends & Drivers

1.3.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Trends

1.3.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Drivers & Opportunity

1.3.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Challenges

1.3.4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Players Revenue Ranking (2023)

2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Company (2019-2024)

2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Players Sales Volume Ranking (2023)

2.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine

2.9 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Competitive Analysis

2.9.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 DTaP

3.1.2 Tdap

3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type

3.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Type

3.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Child

4.1.2 Adult

4.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application

4.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Application

4.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region

5.1.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region

5.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

5.4.2 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

5.5.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

5.7.2 South America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value

6.2.1 Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

6.3.2 United States Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

6.4.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

6.5.2 China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

6.6.2 Japan Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

6.7.2 South Korea Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019-2030

6.9.2 India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi

7.1.1 Sanofi Company Information

7.1.2 Sanofi Introduction and Business Overview

7.1.3 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

7.1.5 Sanofi Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

7.2.5 GSK Recent Development

7.3 KM Biologics

7.3.1 KM Biologics Company Information

7.3.2 KM Biologics Introduction and Business Overview

7.3.3 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

7.3.5 KM Biologics Recent Development

7.4 Serum Institute of India

7.4.1 Serum Institute of India Company Information

7.4.2 Serum Institute of India Introduction and Business Overview

7.4.3 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

7.4.5 Serum Institute of India Recent Development

7.5 Walvax Biotechnology

7.5.1 Walvax Biotechnology Company Information

7.5.2 Walvax Biotechnology Introduction and Business Overview

7.5.3 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

7.5.5 Walvax Biotechnology Recent Development

7.6 Sinopharm

7.6.1 Sinopharm Company Information

7.6.2 Sinopharm Introduction and Business Overview

7.6.3 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

7.6.5 Sinopharm Recent Development

8 Industry Chain Analysis

8.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industrial Chain

8.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

GSK

Sanofi

KM Biologics

Serum Institute of India

Walvax Biotechnology

Sinopharm

List of Tables

Table 1. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Trends

Table 2. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Drivers & Opportunity

Table 3. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Challenges

Table 4. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Restraints

Table 5. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine

Table 13. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Sanofi Company Information

Table 58. Sanofi Introduction and Business Overview

Table 59. Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

Table 61. Sanofi Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

Table 66. GSK Recent Development

Table 67. KM Biologics Company Information

Table 68. KM Biologics Introduction and Business Overview

Table 69. KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

Table 71. KM Biologics Recent Development

Table 72. Serum Institute of India Company Information

Table 73. Serum Institute of India Introduction and Business Overview

Table 74. Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

Table 76. Serum Institute of India Recent Development

Table 77. Walvax Biotechnology Company Information

Table 78. Walvax Biotechnology Introduction and Business Overview

Table 79. Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

Table 81. Walvax Biotechnology Recent Development

Table 82. Sinopharm Company Information

Table 83. Sinopharm Introduction and Business Overview

Table 84. Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offerings

Table 86. Sinopharm Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Downstream Customers

Table 90. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Picture

Figure 2. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Report Years Considered

Figure 7. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue in 2023

Figure 10. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. DTaP Picture

Figure 12. Tdap Picture

Figure 13. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Child

Figure 19. Product Picture of Adult

Figure 20. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industrial Chain

Figure 59. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025

Global DTaP and Tdap Vaccines Market Insights Forecast to 2030

Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Research Report 2024

Global DPT Vaccines Market Research Report 2025

Global DPT Vaccination Market Research Report 2025

Global Combination Vaccines for Children Market Research Report 2024

Global Pertussis Vaccine Market Insights Forecast to 2030

Global Pertussis Vaccination Market Research Report 2025

Global TD Vaccine Market Research Report 2025

Global Acellular DTP Vaccine Market Research Report 2024

Global Pertussis Booster Vaccine Market Research Report 2024

Global Combined Polio Vaccine Market Research Report 2024

Global Tetanus Vaccine Market Insights Forecast to 2030

Global Pentavalent Vaccine Market Research Report 2024

Diphtheria Tetanus Pertussis Mix Vaccine for Children Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global DT Based Combined Vaccines Market Research Report 2024

Global Diphtheria Vaccines Market Research Report 2024

Global Pediatric Preventable Vaccine Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions